Skip to main content
. Author manuscript; available in PMC: 2013 Dec 22.
Published in final edited form as: Mol Pharm. 2012 Jun 22;9(8):2280–2289. doi: 10.1021/mp300152v

Figure 2.

Figure 2

Cellular uptake of siRNA in vitro. (a) Fluorescence photographs of cultured A549 cells after treatment with 5′-FAM-labeled oligo in non-targeted or targeted LCP for 4 h. (b) Quantitative measurement of mean fluorescence intensity of cell lysate from A549 cells treated with 5′-FAM-labeled oligo formulated in non-targeted or targeted LCP. A549 cells were incubated at 37 °C for 4 h in the absence or presence of 50 μM haloperidol. Columns, mean (n = 3); bars, SD. *, p < 0.05.